Proteomic phenotyping: metastatic and invasive breast cancer
- 14 March 2004
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 210 (2) , 245-253
- https://doi.org/10.1016/j.canlet.2004.01.019
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Highly Altered Protein Expression Profile in the Adriamycin Resistant MCF-7 Cell LineJournal of Proteome Research, 2003
- Multidrug-Resistant MCF-7 Cells: An Identity Crisis?JNCI Journal of the National Cancer Institute, 2002
- Uncertain Identity of Doxorubicin-Resistant MCF-7 Cell Lines Expressing Mutated p53JNCI Journal of the National Cancer Institute, 2000
- Systematic variation in gene expression patterns in human cancer cell linesNature Genetics, 2000
- A multidrug resistance transporter from human MCF-7 breast cancer cellsProceedings of the National Academy of Sciences, 1998
- Cell line designation change: multidrug-resistant cell line in the NCI anticancer screen.JNCI Journal of the National Cancer Institute, 1998
- Decreased melphalan accumulation in a human breast cancer cell line selected for resistance to melphalanBritish Journal of Cancer, 1993
- A Multidrug-Resistant MCF-7 Human Breast Cancer Cell Line Which Exhibits Cross-Resistance to Antiestrogens and Hormone-Independent Tumor Growthin VivoMolecular Endocrinology, 1988
- Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterizationIn Vitro Cellular & Developmental Biology - Plant, 1978
- A Human Cell Line From a Pleural Effusion Derived From a Breast Carcinoma 2JNCI Journal of the National Cancer Institute, 1973